A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

CASI Insider Trading (CASI Pharmaceuticals)

Insider Ownership Percentage: 26.59%
Insider Buying (Last 12 Months): $198,000.00
Insider Selling (Last 12 Months): $0.00

CASI Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at CASI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CASI Pharmaceuticals Share Price & Price History

Current Price: $3.01
Price Change: Price Increase of +0.51 (20.40%)
As of 08/10/2022 01:00 AM ET

This chart shows the closing price history over time for CASI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

CASI Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2021Wei-Wu HeCEOBuy200,000$0.99$198,000.00View SEC Filing Icon  
3/26/2021Wei-Wu HeCEOBuy3,000,000$2.05$6,150,000.004,683,994View SEC Filing Icon  
12/16/2020Weihao XuCFOBuy2,000$2.44$4,880.00View SEC Filing Icon  
7/22/2020Larry ZhangPresidentBuy20,153$1.90$38,290.7020,153View SEC Filing Icon  
7/22/2020Wei-Wu HeCEOBuy2,952,426$1.90$5,609,609.404,836,523View SEC Filing Icon  
5/20/2020Wei-Wu HeCEOBuy86,265$2.61$225,151.651,827,663View SEC Filing Icon  
5/18/2020Wei-Wu HeCEOBuy438,932$2.05$899,810.601,827,663View SEC Filing Icon  
3/27/2020Wei-Wu HeCEOBuy6,880$2.09$14,379.201,358,900View SEC Filing Icon  
3/25/2020Wei-Wu HeCEOBuy196,398$1.94$381,012.121,023,925View SEC Filing Icon  
3/19/2020Wei-Wu HeCEOBuy234,488$1.57$368,146.16827,527View SEC Filing Icon  
3/17/2020Wei-Wu HeCEOBuy264,192$1.50$396,288.00827,527View SEC Filing Icon  
8/16/2019Wei-Wu HeCEOBuy20,000$3.20$64,000.00827,527View SEC Filing Icon  
8/14/2019Brian D ColemanCFOBuy20,000$2.44$48,800.00
8/14/2019Wei-Wu HeCEOBuy160,000$3.17$507,200.00807,527View SEC Filing Icon  
See Full Table
Will This Be the Worst U.S. Crisis Ever?
Wealthy 73-year-old U.S. entrepreneur retreats to one of his three European properties to issue serious warning (and 4 recommendations) for Americans. "It falls on someone like me to warn you clearly. I'm too rich to care about money—and too old to care what anyone thinks."
Click here for details...

SEC Filings (Institutional Ownership Changes) for CASI Pharmaceuticals (NASDAQ:CASI)

39.51% of CASI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CASI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CASI Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/27/2022Bailard Inc.31,530$90K0.0%+25.6%0.232%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC112,777$91K0.0%+39.6%0.083%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC155,300$0.13M0.0%-89.3%0.114%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,061,331$2.48M0.0%-20.5%2.241%Search for SEC Filing on Google Icon
5/12/2022Wellington Shields Capital Management LLC2,132,547$1.73M0.2%-2.6%1.561%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.73,117$59K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/11/2022Roundview Capital LLC38,112$31K0.0%-68.9%0.028%Search for SEC Filing on Google Icon
5/9/2022Wellington Shields & Co. LLC1,453,190$1.18M0.4%+27.3%1.064%Search for SEC Filing on Google Icon
2/16/2022Wellington Shields & Co. LLC1,141,190$0.91M0.2%-37.7%0.816%Search for SEC Filing on Google Icon
2/15/2022Wellington Shields Capital Management LLC2,188,547$1.75M0.2%-3.1%1.566%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP952,037$1.13M0.0%+325.6%0.681%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC1,618,155$1.93M0.0%+4.6%1.158%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC944,729$1.12M0.0%+34.2%0.676%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.60,904$72K0.0%N/A0.044%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.199,986$0.24M0.0%+32.3%0.143%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,165,942$1.39M0.0%-1.3%0.834%Search for SEC Filing on Google Icon
8/26/2021Y Intercept Hong Kong Ltd16,246$25K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP223,709$0.35M0.0%N/A0.160%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC1,112,208$1.72M0.0%+1,211.7%0.796%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD105,200$0.16M0.0%-32.3%0.075%Search for SEC Filing on Google Icon
8/17/2021Prudential Financial Inc.16,600$26K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC185,988$0.29M0.0%+14.8%0.133%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC22,698$35K0.0%+107.4%0.016%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP30,360$47K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC20,600$32K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.405,290$0.63M0.0%-20.0%0.290%Search for SEC Filing on Google Icon
8/16/2021State Street Corp194,842$0.30M0.0%-81.3%0.139%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd216,300$0.34M0.1%N/A0.155%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.151,183$0.23M0.0%+143.6%0.108%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP223,709$0.35M0.0%N/A0.160%Search for SEC Filing on Google Icon
8/16/2021Wellington Shields Capital Management LLC2,258,264$3.50M0.4%+1.2%1.615%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC1,546,306$2.40M0.0%+504.7%1.106%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp243,200$0.38M0.0%-70.4%0.174%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC703,888$1.09M0.0%-35.6%0.504%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.3,904,627$6.05M0.0%-7.6%2.793%Search for SEC Filing on Google Icon
8/13/2021Bailard Inc.40,400$63K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP274,344$0.43M0.0%+4.6%0.196%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.191,523$0.30M0.0%+8.7%0.137%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC300,400$0.47M0.0%N/A0.215%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp36,436$56K0.0%-80.6%0.026%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,181,599$1.83M0.0%-70.5%0.845%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP78,572$0.12M0.0%+377.9%0.056%Search for SEC Filing on Google Icon
8/1/2021Sterneck Capital Management LLC40,000$47K0.0%N/A0.029%Search for SEC Filing on Google Icon
7/31/2021Mosaic Family Wealth LLC17,500$27K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC66,106$0.16M0.0%+431.0%0.047%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC10,943$26K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC84,791$0.20M0.0%-34.3%0.061%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.22,596$54K0.0%N/A0.016%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC21,100$51K0.0%+51.5%0.015%Search for SEC Filing on Google Icon
5/17/2021Aristides Capital LLC63,250$0.15M0.1%N/A0.045%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD155,288$0.37M0.0%+37.5%0.111%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC283,079$0.68M0.0%+20.4%0.202%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.62,052$0.15M0.0%+109.8%0.044%Search for SEC Filing on Google Icon
5/14/2021Ghost Tree Capital LLC650,000$1.56M0.4%N/A0.465%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP262,374$0.63M0.0%+766.2%0.188%Search for SEC Filing on Google Icon
5/14/2021Vident Investment Advisory LLC54,829$0.13M0.0%-39.3%0.039%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd14,215$34K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC55,269$0.13M0.0%+159.0%0.040%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC255,700$0.61M0.0%+261.1%0.183%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.10,150,000$24.36M0.0%+45.0%7.261%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp820,622$1.97M0.0%-12.7%0.587%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,092,677$2.62M0.0%+14.1%0.782%Search for SEC Filing on Google Icon
5/12/2021Wellington Shields & Co. LLC1,832,769$4.40M1.6%+1.1%1.311%Search for SEC Filing on Google Icon
5/12/2021Wellington Shields Capital Management LLC2,231,765$5.36M0.5%+7.7%1.596%Search for SEC Filing on Google Icon
5/12/20211492 Capital Management LLC79,743$0.19M0.1%N/A0.057%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.176,221$0.42M0.0%-4.2%0.126%Search for SEC Filing on Google Icon
5/12/2021Panagora Asset Management Inc.125,747$0.30M0.0%N/A0.090%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP16,442$39K0.0%-68.5%0.012%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.4,006,960$9.62M0.0%+4.6%2.866%Search for SEC Filing on Google Icon
5/6/2021Quantitative Systematic Strategies LLC21,561$52K0.0%N/A0.015%Search for SEC Filing on Google Icon
4/30/2021Creative Planning40,009$96K0.0%N/A0.029%Search for SEC Filing on Google Icon
4/12/2021FNY Investment Advisers LLC49,400$0.12M0.0%N/A0.035%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP13,290$39K0.0%-50.2%0.011%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP30,290$89K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP30,290$89K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC12,450$37K0.0%-67.7%0.010%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.14,414$43K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.183,922$0.54M0.0%+281.1%0.148%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD112,917$0.33M0.0%+53.7%0.091%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.480,106$1.42M0.0%+1.7%0.387%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.7,000,000$20.65M0.0%+1.4%5.648%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company45,064$0.13M0.0%+121.5%0.036%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC1,268,154$3.74M0.2%-17.6%1.023%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG19,406$57K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp940,103$2.77M0.0%+3.8%0.758%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC21,341$63K0.0%-28.3%0.017%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.11,781$35K0.0%+271.1%0.010%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers73,286$0.22M0.0%+11.5%0.059%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC70,813$0.21M0.0%-88.2%0.057%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN169,768$0.50M0.0%+4.2%0.137%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp187,679$0.55M0.0%+6.8%0.151%Search for SEC Filing on Google Icon
2/9/2021Wellington Shields Capital Management LLC2,071,765$6.11M0.8%+45.4%1.672%Search for SEC Filing on Google Icon
2/9/2021Wellington Shields & Co. LLC1,812,769$5.35M1.9%+22.5%1.463%Search for SEC Filing on Google Icon
2/9/2021ProShare Advisors LLC14,651$43K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.3,830,466$11.30M0.0%+9.1%3.090%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP52,146$0.15M0.0%+157.4%0.042%Search for SEC Filing on Google Icon
2/4/2021State of Wisconsin Investment Board91,900$0.27M0.0%N/A0.074%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC38,496$59K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/16/2020Squarepoint Ops LLC19,637$30K0.0%N/A0.016%Search for SEC Filing on Google Icon
11/16/2020Boothbay Fund Management LLC196,653$0.30M0.0%+41.3%0.159%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CASI Pharmaceuticals logo
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.
Read More on CASI Pharmaceuticals

Today's Range

Now: $3.01
Low: $2.48
High: $3.02

50 Day Range

MA: $2.85
Low: $2.36
High: $3.71

52 Week Range

Now: $3.01
Low: $2.24
High: $17.40

Volume

331,006 shs

Average Volume

74,797 shs

Market Capitalization

$40.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Who are the company insiders with the largest holdings of CASI Pharmaceuticals?

CASI Pharmaceuticals' top insider investors include:
  1. Wei-Wu He (CEO)
  2. Weihao Xu (CFO)
Learn More about top insider investors at CASI Pharmaceuticals.

Who are the major institutional investors of CASI Pharmaceuticals?

CASI Pharmaceuticals' top institutional investors include:
  1. Bailard Inc. — 0.23%
Learn More about top institutional investors of CASI Pharmaceuticals stock.

Which major investors are buying CASI Pharmaceuticals stock?

In the last quarter, CASI stock was acquired by institutional investors including:
  1. Bailard Inc.
During the previous year, these company insiders have bought CASI Pharmaceuticals stock:
  1. Wei-Wu He (CEO)
  2. Weihao Xu (CFO)
Learn More investors buying CASI Pharmaceuticals stock.
New $2.2 Quadrillion Trend About To Open Up
Massive Opportunities For Investors
Continue Reading